- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7024 - Esters of saccharides
Patent holdings for IPC class A61K 31/7024
Total number of patents in this class: 485
10-year publication summary
|
21
|
39
|
38
|
53
|
32
|
38
|
33
|
33
|
35
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Johns Hopkins University | 5651 |
10 |
| Memorial Sloan-Kettering Cancer Center | 1914 |
8 |
| SeaGen Inc | 586 |
7 |
| Board of Regents, The University of Texas System | 5760 |
6 |
| China Pharmaceutical University | 295 |
6 |
| Adjuvance Technologies, Inc., AKA Adjuvance | 22 |
5 |
| The Feinstein Institute for Medical Research | 250 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3137 |
5 |
| Risen (Suzhou) Pharma Tech Co., Ltd. | 65 |
5 |
| Centre National de La Recherche Scientifique | 10395 |
4 |
| Horphag Research IP (qr) Ltd | 4 |
4 |
| Immune Design Corp. | 36 |
4 |
| Jinan University | 229 |
4 |
| The Kitasato Institute | 151 |
4 |
| Oryza Oil & Fat Chemical Co., Ltd. | 29 |
4 |
| Seattle Genetics, Inc. | 104 |
4 |
| Suntory Holdings Limited | 2010 |
4 |
| VDF FutureCeuticals, Inc. | 161 |
4 |
| Nectero Medical, Inc. | 19 |
4 |
| Eisai R&D Management Co., Ltd. | 1237 |
4 |
| Other owners | 384 |